Cumberland Pharmaceuticals PE ratio CPIX

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 232×; Aug 2016
Peer median: 11.3×

Cumberland Pharmaceuticals has no meaningful PE ratio today: it lost $0.73 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Aug 2016, at 232×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2016	232×	65.6×	243×
2015	75.1×	45.3×	348×
2014	301×	66.1×	301×
2013	73.7×	14.6×	73.7×
2012	16.5×	16.5×	26.9×

Against its peers

Companies in Drug Manufacturers - General nearest Cumberland Pharmaceuticals' size, closest first, today.

Company	PE ratio
CPIXCumberland Pharmaceuticals	n/m
NATRNatures Sunshine Products	12.0×
LFVNLifevantage	14.7×
SPROSpero Therapeutics	10.1×
ATNMActinium Pharmaceuticals	4.2×
ARVNArvinas	45.6×
PBYIPuma Biotechnology	21.2×
IRWDIronwood Pharmaceuticals	4.5×
ZVRAZevra Therapeutics	10.5×
CRMDCorMedix	3.7×
COLLCollegium Pharmaceutical	18.5×
Peer median	11.3×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Cumberland Pharmaceuticals

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.